Placebo Effect
"Placebo Effect" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion.
Descriptor ID |
D015990
|
MeSH Number(s) |
N05.715.350.350.625 N06.850.490.734.875
|
Concept/Terms |
Placebo Effect- Placebo Effect
- Effect, Placebo
- Effects, Placebo
- Placebo Effects
|
Below are MeSH descriptors whose meaning is more general than "Placebo Effect".
Below are MeSH descriptors whose meaning is more specific than "Placebo Effect".
This graph shows the total number of publications written about "Placebo Effect" by people in this website by year, and whether "Placebo Effect" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 | 1998 | 0 | 1 | 1 | 1999 | 0 | 1 | 1 | 2000 | 1 | 0 | 1 | 2002 | 1 | 0 | 1 | 2003 | 1 | 0 | 1 | 2006 | 0 | 1 | 1 | 2008 | 1 | 2 | 3 | 2011 | 0 | 1 | 1 | 2012 | 0 | 1 | 1 | 2013 | 1 | 0 | 1 | 2014 | 0 | 2 | 2 | 2018 | 1 | 0 | 1 | 2019 | 0 | 1 | 1 | 2020 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Placebo Effect" by people in Profiles.
-
Anderson S, Stebbins GT. Determinants of placebo effects. Int Rev Neurobiol. 2020; 153:27-47.
-
Agarwal S, Scher E, Lord A, Frontera J, Ishida K, Torres J, Rostanski S, Mistry E, Mac Grory B, Cutting S, Burton T, Silver B, Liberman AL, Lerario MP, Furie K, Grotta J, Khatri P, Saver J, Yaghi S. Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo. Stroke. 2020 04; 51(4):1226-1230.
-
Witek NP, Goetz CG, Stebbins GT. Preface. Int Rev Neurobiol. 2020; 153:xi-xii.
-
Hofmann SG, Papini S, Carpenter JK, Otto MW, Rosenfield D, Dutcher CD, Dowd S, Lewis M, Witcraft S, Pollack MH, Smits JAJ. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder. PLoS One. 2019; 14(10):e0223729.
-
Witek N, Stebbins GT, Goetz CG. What influences placebo and nocebo responses in Parkinson's disease? Mov Disord. 2018 08; 33(8):1204-1212.
-
Ballany W, Mansour K, Morales Demori R, Al-Amoodi M, Doukky R. The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial. J Nucl Cardiol. 2014 Jun; 21(3):496-502.
-
Shi Y, Robb MJ, Michaelides EM. Medical management of tinnitus: role of the physician. J Am Acad Audiol. 2014 Jan; 25(1):23-8.
-
Cubo E, González M, Singer H, Mahone EM, Scahill L, Müller-Vahl KR, de la Fuente-Fernández R, Armesto D, Kompoliti K. Impact of placebo assignment in clinical trials of tic disorders. Mov Disord. 2013 Aug; 28(9):1288-92.
-
Doukky R, Morales Demori R, Jain S, Kiriakos R, Mwansa V, Calvin JE. Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial". J Nucl Cardiol. 2012 Jun; 19(3):448-57.
-
Goetz CG. The history of Parkinson's disease: early clinical descriptions and neurological therapies. Cold Spring Harb Perspect Med. 2011 Sep; 1(1):a008862.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|